Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07690917 · ClinicalTrials.gov registry record
A Study of a New PET Scanner in People With Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 90
- Enrollment target
NCT07690917: Recruiting study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT07690917 is a clinical trial that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07690917 is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 90 participants
- Enrollment target
Study Summary
The researchers are doing this study to test the capabilities of a new total-body PET scanner called the Biograph Vision Quadra. The researchers want to learn whether this scanner can produce better PET/CT images and provide more useful imaging information than standard PET/CT scanners.
Interventions
- DIAGNOSTIC_TEST PET/CT
- DIAGNOSTIC_TEST Biograph Vision Quadra scanner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2026-06-30 |
| Est. Completion | 2029-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07690917
The ClinicalTrials.gov registry entry for NCT07690917 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PET/CT is the first listed.
NCT07690917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07690917 about?
NCT07690917 is a clinical study titled "A Study of a New PET Scanner in People With Cancer". The researchers are doing this study to test the capabilities of a new total-body PET scanner called the Biograph Vision Quadra. The researchers want to learn whether this scanner can produce better PET/CT images and provide more useful imaging information than standard PET/CT scanners.
What is the current status of trial NCT07690917?
This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2026-06-30. Estimated completion is 2029-06.
What interventions are being tested in trial NCT07690917?
The interventions under investigation include: PET/CT (DIAGNOSTIC_TEST), Biograph Vision Quadra scanner (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07690917?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.